I-131 labeling of tamoxifen and biodistribution studies in rats
dc.contributor.author | Muftuler, F. Z. Biber | |
dc.contributor.author | Unak, P. | |
dc.contributor.author | Teksoz, S. | |
dc.contributor.author | Acar, C. | |
dc.contributor.author | Yolcular, S. | |
dc.contributor.author | Yurekli, Y. | |
dc.date.accessioned | 2019-10-27T19:55:26Z | |
dc.date.available | 2019-10-27T19:55:26Z | |
dc.date.issued | 2008 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Tamoxifen [TAM ([Z]-2-[4-(1,2-diphenyl-1-di-butenyl)-phenoxy]-N,N-dimethylethanamine)] has been used as an antiestrogen drug for treatment and prevention of human breast cancer. Tamoxifen was labeled with I-131 using iodogen as an oxidizing agent. Mass spectroscopy of the cold standard showed that the labeling occurs in ortho position to the phenyl ether position of TAM as expected. Quality control, radiochemical yield and stability were established using the radioelectrophoresis method. The radiolabeled compound maintained its stability throughout working period of 24 h. Scintigraphic imaging was performed and tissue distribution was determined in Albino Wistar rats. According to biodistribution and imaging experiments the radiolabeled compound presented estrogen receptor (ER) specificity and it was uptaken by endometrium as well as breast tissue. (C) 2007 Elsevier Ltd. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/j.apradiso.2007.08.005 | en_US |
dc.identifier.endpage | 187 | en_US |
dc.identifier.issn | 0969-8043 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 17888670 | en_US |
dc.identifier.startpage | 178 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.apradiso.2007.08.005 | |
dc.identifier.uri | https://hdl.handle.net/11454/40681 | |
dc.identifier.volume | 66 | en_US |
dc.identifier.wos | WOS:000253103100011 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Applied Radiation and Isotopes | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | antiestrogen | en_US |
dc.subject | I-131 | en_US |
dc.subject | iodogen (1,3,4,6-tetrachloro-3 alpha,6 alpha)-diphenylglycouril) | en_US |
dc.subject | I-131-TAM | en_US |
dc.title | I-131 labeling of tamoxifen and biodistribution studies in rats | en_US |
dc.type | Article | en_US |